Skip to main content
LLY
NYSE Life Sciences

Eli Lilly Launches Foundayo Weight-Loss Pill in U.K., First European Market

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1,256.62
Mkt Cap
$1.182T
52W Low
$694.23
52W High
$1,292.65
52W Position info
81% above low
Off High info
2.8% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LLY sits 81% above its 52-week low of $694.23.

Summary

Eli Lilly has launched its oral weight-loss drug Foundayo in the U.K., the first European market for the product. The once-daily pill is available via private prescription starting this week, with NHS coverage still under assessment. U.K. regulators approved Foundayo earlier this month for weight loss and type 2 diabetes. This follows the FDA approval noted in the Q2 10-Q and positions Lilly against Novo Nordisk's Wegovy pill, which launched in the U.K. in July and has already reached ~300,000 patients. The launch expands Foundayo's commercial footprint into a key European market and intensifies competition in the oral GLP-1 space.

At the time of this announcement, LLY was trading at $1,256.62 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.2T. The 52-week trading range was $694.23 to $1,292.65. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 09, 2026, 10:23 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1,394.15
Real-time Price: $1,411.12 info
Change: +$16.97 (+1%) info
Market Cap: $1.328T info
LLY
Nov 06, 2026, 6:45 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,346.00
Real-time Price: $1,411.12 info
Change: +$65.12 (+5%) info
Market Cap: $1.328T info
LLY
Nov 04, 2026, 1:53 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,416.54
Real-time Price: $1,411.12 info
Change: -$5.42 (-0.38%) info
Market Cap: $1.328T info
LLY
Oct 29, 2026, 3:21 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1,368.10
Real-time Price: $1,411.12 info
Change: +$43.02 (+3%) info
Market Cap: $1.328T info
LLY
Oct 29, 2026, 12:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1,370.30
Real-time Price: $1,411.12 info
Change: +$40.82 (+3%) info
Market Cap: $1.328T info